 | • レポートコード：D0GIR-06048 • 出版社/出版日：GlobalInfoResearch / 2020年9月18日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、104ページ • 納品方法：Eメール • 産業分類：医療、製薬、バイオ |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートでは、抗肥満薬の世界市場を広く調査・分析し、今後の市場展望をまとめております。抗肥満薬の種類別市場規模（末梢性抗肥満薬、中枢性抗肥満薬）、用途別市場規模（子供、大人）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、メーカー別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・市場概要 ・メーカー情報（販売量、市場シェア、製品概要、SWOT分析）：Merck、Vivus、Arena Pharmaceuticals、Novo Nordisk、Orexigen Therapeutics、Pfizer、Alizyme、GlaxoSmithKline、Roche、Amylin、Boehringer Ingelheim、Eisai ・地域別グローバル市場分析 2015年-2020年 ・抗肥満薬の北米市場（アメリカ、カナダ、メキシコ） ・抗肥満薬のヨーロッパ市場（ドイツ、イギリス、フランス、ロシア、イタリア） ・抗肥満薬のアジア市場（中国、日本、韓国、インド、東南アジア、オーストラリア） ・抗肥満薬の南米市場（ブラジル、アルゼンチン） ・抗肥満薬の中東・アフリカ市場（サウジアラビア、トルコ、エジプト、南アフリカ） ・種類別分析：末梢性抗肥満薬、中枢性抗肥満薬 ・用途別分析：子供、大人 ・地域別市場規模予測 2021年-2025年 ・販売チャネル、流通業者、代理店 ・調査の結果・結論 |
Market Overview
The global Anti-obesity Drugs market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.
The Anti-obesity Drugs market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
Market segmentation
Anti-obesity Drugs market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Anti-obesity Drugs market has been segmented into
Peripherally Acting Anti-obesity Drugs
Centrally Acting Anti-obesity Drugs
By Application, Anti-obesity Drugs has been segmented into:
Kids
Adults
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Anti-obesity Drugs market presented in the report. This section sheds light on the sales growth of different regional and country-level Anti-obesity Drugs markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Anti-obesity Drugs market.
The report offers in-depth assessment of the growth and other aspects of the Anti-obesity Drugs market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, etc.)
Middle East & Africa (Saudi Arabia, Egypt, Nigeria and South Africa)
Competitive Landscape and Anti-obesity Drugs Market Share Analysis
Anti-obesity Drugs competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Anti-obesity Drugs sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Anti-obesity Drugs sales, revenue and market share for each player covered in this report.
The major players covered in Anti-obesity Drugs are:
Merck
Vivus
Arena Pharmaceuticals
Novo Nordisk
Orexigen Therapeutics
Pfizer
Alizyme
GlaxoSmithKline
Roche
Amylin
Boehringer Ingelheim
Eisai
Among other players domestic and global, Anti-obesity Drugs market share data is available for global, North America, Europe, Asia-Pacific, Middle East and Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Anti-obesity Drugs product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Anti-obesity Drugs, with price, sales, revenue and global market share of Anti-obesity Drugs in 2018 and 2019.
Chapter 3, the Anti-obesity Drugs competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Anti-obesity Drugs breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2015 to 2020.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2015 to 2020.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2015 to 2020.
Chapter 12, Anti-obesity Drugs market forecast, by regions, type and application, with sales and revenue, from 2020 to 2025.
Chapter 13, 14 and 15, to describe Anti-obesity Drugs sales channel, distributors, customers, research findings and conclusion, appendix and data source.
Table of Contents
1 Market Overview
1.1 Anti-obesity Drugs Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Anti-obesity Drugs Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Peripherally Acting Anti-obesity Drugs
1.2.3 Centrally Acting Anti-obesity Drugs
1.3 Market Analysis by Application
1.3.1 Overview: Global Anti-obesity Drugs Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Kids
1.3.3 Adults
1.4 Overview of Global Anti-obesity Drugs Market
1.4.1 Global Anti-obesity Drugs Market Status and Outlook (2015-2025)
1.4.2 North America (United States, Canada and Mexico)
1.4.3 Europe (Germany, France, United Kingdom, Russia and Italy)
1.4.4 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.5 South America, Middle East & Africa
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Merck
2.1.1 Merck Details
2.1.2 Merck Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Merck SWOT Analysis
2.1.4 Merck Product and Services
2.1.5 Merck Anti-obesity Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.2 Vivus
2.2.1 Vivus Details
2.2.2 Vivus Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Vivus SWOT Analysis
2.2.4 Vivus Product and Services
2.2.5 Vivus Anti-obesity Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.3 Arena Pharmaceuticals
2.3.1 Arena Pharmaceuticals Details
2.3.2 Arena Pharmaceuticals Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Arena Pharmaceuticals SWOT Analysis
2.3.4 Arena Pharmaceuticals Product and Services
2.3.5 Arena Pharmaceuticals Anti-obesity Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.4 Novo Nordisk
2.4.1 Novo Nordisk Details
2.4.2 Novo Nordisk Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Novo Nordisk SWOT Analysis
2.4.4 Novo Nordisk Product and Services
2.4.5 Novo Nordisk Anti-obesity Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.5 Orexigen Therapeutics
2.5.1 Orexigen Therapeutics Details
2.5.2 Orexigen Therapeutics Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Orexigen Therapeutics SWOT Analysis
2.5.4 Orexigen Therapeutics Product and Services
2.5.5 Orexigen Therapeutics Anti-obesity Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.6 Pfizer
2.6.1 Pfizer Details
2.6.2 Pfizer Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Pfizer SWOT Analysis
2.6.4 Pfizer Product and Services
2.6.5 Pfizer Anti-obesity Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.7 Alizyme
2.7.1 Alizyme Details
2.7.2 Alizyme Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 Alizyme SWOT Analysis
2.7.4 Alizyme Product and Services
2.7.5 Alizyme Anti-obesity Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.8 GlaxoSmithKline
2.8.1 GlaxoSmithKline Details
2.8.2 GlaxoSmithKline Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 GlaxoSmithKline SWOT Analysis
2.8.4 GlaxoSmithKline Product and Services
2.8.5 GlaxoSmithKline Anti-obesity Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.9 Roche
2.9.1 Roche Details
2.9.2 Roche Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 Roche SWOT Analysis
2.9.4 Roche Product and Services
2.9.5 Roche Anti-obesity Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.10 Amylin
2.10.1 Amylin Details
2.10.2 Amylin Major Business and Total Revenue (Financial Highlights) Analysis
2.10.3 Amylin SWOT Analysis
2.10.4 Amylin Product and Services
2.10.5 Amylin Anti-obesity Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.11 Boehringer Ingelheim
2.11.1 Boehringer Ingelheim Details
2.11.2 Boehringer Ingelheim Major Business and Total Revenue (Financial Highlights) Analysis
2.11.3 Boehringer Ingelheim SWOT Analysis
2.11.4 Boehringer Ingelheim Product and Services
2.11.5 Boehringer Ingelheim Anti-obesity Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.12 Eisai
2.12.1 Eisai Details
2.12.2 Eisai Major Business and Total Revenue (Financial Highlights) Analysis
2.12.3 Eisai SWOT Analysis
2.12.4 Eisai Product and Services
2.12.5 Eisai Anti-obesity Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
3 Sales, Revenue and Market Share by Manufacturer
3.1 Global Anti-obesity Drugs Sales and Market Share by Manufacturer (2018-2019)
3.2 Global Anti-obesity Drugs Revenue and Market Share by Manufacturer (2018-2019)
3.3 Market Concentration Rate
3.3.1 Top 3 Anti-obesity Drugs Manufacturer Market Share in 2019
3.3.2 Top 6 Anti-obesity Drugs Manufacturer Market Share in 2019
3.4 Market Competition Trend
4 Global Market Analysis by Regions
4.1 Global Anti-obesity Drugs Sales, Revenue and Market Share by Regions
4.1.1 Global Anti-obesity Drugs Sales and Market Share by Regions (2015-2020)
4.1.2 Global Anti-obesity Drugs Revenue and Market Share by Regions (2015-2020)
4.2 North America Anti-obesity Drugs Sales and Growth Rate (2015-2020)
4.3 Europe Anti-obesity Drugs Sales and Growth Rate (2015-2020)
4.4 Asia-Pacific Anti-obesity Drugs Sales and Growth Rate (2015-2020)
4.5 South America Anti-obesity Drugs Sales and Growth Rate (2015-2020)
4.6 Middle East and Africa Anti-obesity Drugs Sales and Growth Rate (2015-2020)
5 North America by Country
5.1 North America Anti-obesity Drugs Sales, Revenue and Market Share by Country
5.1.1 North America Anti-obesity Drugs Sales and Market Share by Country (2015-2020)
5.1.2 North America Anti-obesity Drugs Revenue and Market Share by Country (2015-2020)
5.2 United States Anti-obesity Drugs Sales and Growth Rate (2015-2020)
5.3 Canada Anti-obesity Drugs Sales and Growth Rate (2015-2020)
5.4 Mexico Anti-obesity Drugs Sales and Growth Rate (2015-2020)
6 Europe by Country
6.1 Europe Anti-obesity Drugs Sales, Revenue and Market Share by Country
6.1.1 Europe Anti-obesity Drugs Sales and Market Share by Country (2015-2020)
6.1.2 Europe Anti-obesity Drugs Revenue and Market Share by Country (2015-2020)
6.2 Germany Anti-obesity Drugs Sales and Growth Rate (2015-2020)
6.3 UK Anti-obesity Drugs Sales and Growth Rate (2015-2020)
6.4 France Anti-obesity Drugs Sales and Growth Rate (2015-2020)
6.5 Russia Anti-obesity Drugs Sales and Growth Rate (2015-2020)
6.6 Italy Anti-obesity Drugs Sales and Growth Rate (2015-2020)
7 Asia-Pacific by Regions
7.1 Asia-Pacific Anti-obesity Drugs Sales, Revenue and Market Share by Regions
7.1.1 Asia-Pacific Anti-obesity Drugs Sales and Market Share by Regions (2015-2020)
7.1.2 Asia-Pacific Anti-obesity Drugs Revenue and Market Share by Regions (2015-2020)
7.2 China Anti-obesity Drugs Sales and Growth Rate (2015-2020)
7.3 Japan Anti-obesity Drugs Sales and Growth Rate (2015-2020)
7.4 Korea Anti-obesity Drugs Sales and Growth Rate (2015-2020)
7.5 India Anti-obesity Drugs Sales and Growth Rate (2015-2020)
7.6 Southeast Asia Anti-obesity Drugs Sales and Growth Rate (2015-2020)
7.7 Australia Anti-obesity Drugs Sales and Growth Rate (2015-2020)
8 South America by Country
8.1 South America Anti-obesity Drugs Sales, Revenue and Market Share by Country
8.1.1 South America Anti-obesity Drugs Sales and Market Share by Country (2015-2020)
8.1.2 South America Anti-obesity Drugs Revenue and Market Share by Country (2015-2020)
8.2 Brazil Anti-obesity Drugs Sales and Growth Rate (2015-2020)
8.3 Argentina Anti-obesity Drugs Sales and Growth Rate (2015-2020)
9 Middle East & Africa by Countries
9.1 Middle East & Africa Anti-obesity Drugs Sales, Revenue and Market Share by Country
9.1.1 Middle East & Africa Anti-obesity Drugs Sales and Market Share by Country (2015-2020)
9.1.2 Middle East & Africa Anti-obesity Drugs Revenue and Market Share by Country (2015-2020)
9.2 Saudi Arabia Anti-obesity Drugs Sales and Growth Rate (2015-2020)
9.3 Turkey Anti-obesity Drugs Sales and Growth Rate (2015-2020)
9.4 Egypt Anti-obesity Drugs Sales and Growth Rate (2015-2020)
9.5 South Africa Anti-obesity Drugs Sales and Growth Rate (2015-2020)
10 Market Segment by Type
10.1 Global Anti-obesity Drugs Sales and Market Share by Type (2015-2020)
10.2 Global Anti-obesity Drugs Revenue and Market Share by Type (2015-2020)
10.3 Global Anti-obesity Drugs Price by Type (2015-2020)
11 Global Anti-obesity Drugs Market Segment by Application
11.1 Global Anti-obesity Drugs Sales Market Share by Application (2015-2020)
11.2 Global Anti-obesity Drugs Revenue Market Share by Application (2015-2020)
11.3 Global Anti-obesity Drugs Price by Application (2015-2020)
12 Market Forecast
12.1 Global Anti-obesity Drugs Sales, Revenue and Growth Rate (2021-2025)
12.2 Anti-obesity Drugs Market Forecast by Regions (2021-2025)
12.2.1 North America Anti-obesity Drugs Market Forecast (2021-2025)
12.2.2 Europe Anti-obesity Drugs Market Forecast (2021-2025)
12.2.3 Asia-Pacific Anti-obesity Drugs Market Forecast (2021-2025)
12.2.4 South America Anti-obesity Drugs Market Forecast (2021-2025)
12.2.5 Middle East & Africa Anti-obesity Drugs Market Forecast (2021-2025)
12.3 Anti-obesity Drugs Market Forecast by Type (2021-2025)
12.3.1 Global Anti-obesity Drugs Sales Forecast by Type (2021-2025)
12.3.2 Global Anti-obesity Drugs Market Share Forecast by Type (2021-2025)
12.4 Anti-obesity Drugs Market Forecast by Application (2021-2025)
12.4.1 Global Anti-obesity Drugs Sales Forecast by Application (2021-2025)
12.4.2 Global Anti-obesity Drugs Market Share Forecast by Application (2021-2025)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
15.3 Disclaimer
15.4 About US
Table 1. Global Anti-obesity Drugs Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Anti-obesity Drugs by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Anti-obesity Drugs Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Market Opportunities in Next Few Years
Table 5. Market Risks Analysis
Table 6. Market Drivers
Table 7. Merck Basic Information, Manufacturing Base and Competitors
Table 8. Merck Anti-obesity Drugs Major Business
Table 9. Merck Anti-obesity Drugs Total Revenue (USD Million) (2018-2019)
Table 10. Merck SWOT Analysis
Table 11. Merck Anti-obesity Drugs Product and Services
Table 12. Merck Anti-obesity Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 13. Vivus Basic Information, Manufacturing Base and Competitors
Table 14. Vivus Anti-obesity Drugs Major Business
Table 15. Vivus Anti-obesity Drugs Total Revenue (USD Million) (2018-2019)
Table 16. Vivus SWOT Analysis
Table 17. Vivus Anti-obesity Drugs Product and Services
Table 18. Vivus Anti-obesity Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 19. Arena Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 20. Arena Pharmaceuticals Anti-obesity Drugs Major Business
Table 21. Arena Pharmaceuticals Anti-obesity Drugs Total Revenue (USD Million) (2018-2019)
Table 22. Arena Pharmaceuticals SWOT Analysis
Table 23. Arena Pharmaceuticals Anti-obesity Drugs Product and Services
Table 24. Arena Pharmaceuticals Anti-obesity Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 25. Novo Nordisk Basic Information, Manufacturing Base and Competitors
Table 26. Novo Nordisk Anti-obesity Drugs Major Business
Table 27. Novo Nordisk Anti-obesity Drugs Total Revenue (USD Million) (2018-2019)
Table 28. Novo Nordisk SWOT Analysis
Table 29. Novo Nordisk Anti-obesity Drugs Product and Services
Table 30. Novo Nordisk Anti-obesity Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 31. Orexigen Therapeutics Basic Information, Manufacturing Base and Competitors
Table 32. Orexigen Therapeutics Anti-obesity Drugs Major Business
Table 33. Orexigen Therapeutics Anti-obesity Drugs Total Revenue (USD Million) (2018-2019)
Table 34. Orexigen Therapeutics SWOT Analysis
Table 35. Orexigen Therapeutics Anti-obesity Drugs Product and Services
Table 36. Orexigen Therapeutics Anti-obesity Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 37. Pfizer Basic Information, Manufacturing Base and Competitors
Table 38. Pfizer Anti-obesity Drugs Major Business
Table 39. Pfizer Anti-obesity Drugs Total Revenue (USD Million) (2018-2019)
Table 40. Pfizer SWOT Analysis
Table 41. Pfizer Anti-obesity Drugs Product and Services
Table 42. Pfizer Anti-obesity Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 43. Alizyme Basic Information, Manufacturing Base and Competitors
Table 44. Alizyme Anti-obesity Drugs Major Business
Table 45. Alizyme Anti-obesity Drugs Total Revenue (USD Million) (2018-2019)
Table 46. Alizyme SWOT Analysis
Table 47. Alizyme Anti-obesity Drugs Product and Services
Table 48. Alizyme Anti-obesity Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 49. GlaxoSmithKline Basic Information, Manufacturing Base and Competitors
Table 50. GlaxoSmithKline Anti-obesity Drugs Major Business
Table 51. GlaxoSmithKline Anti-obesity Drugs Total Revenue (USD Million) (2018-2019)
Table 52. GlaxoSmithKline SWOT Analysis
Table 53. GlaxoSmithKline Anti-obesity Drugs Product and Services
Table 54. GlaxoSmithKline Anti-obesity Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 55. Roche Basic Information, Manufacturing Base and Competitors
Table 56. Roche Anti-obesity Drugs Major Business
Table 57. Roche Anti-obesity Drugs Total Revenue (USD Million) (2018-2019)
Table 58. Roche SWOT Analysis
Table 59. Roche Anti-obesity Drugs Product and Services
Table 60. Roche Anti-obesity Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 61. Amylin Basic Information, Manufacturing Base and Competitors
Table 62. Amylin Anti-obesity Drugs Major Business
Table 63. Amylin Anti-obesity Drugs Total Revenue (USD Million) (2018-2019)
Table 64. Amylin SWOT Analysis
Table 65. Amylin Anti-obesity Drugs Product and Services
Table 66. Amylin Anti-obesity Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 67. Boehringer Ingelheim Basic Information, Manufacturing Base and Competitors
Table 68. Boehringer Ingelheim Anti-obesity Drugs Major Business
Table 69. Boehringer Ingelheim Anti-obesity Drugs Total Revenue (USD Million) (2018-2019)
Table 70. Boehringer Ingelheim SWOT Analysis
Table 71. Boehringer Ingelheim Anti-obesity Drugs Product and Services
Table 72. Boehringer Ingelheim Anti-obesity Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 73. Eisai Basic Information, Manufacturing Base and Competitors
Table 74. Eisai Anti-obesity Drugs Major Business
Table 75. Eisai Anti-obesity Drugs Total Revenue (USD Million) (2018-2019)
Table 76. Eisai SWOT Analysis
Table 77. Eisai Anti-obesity Drugs Product and Services
Table 78. Eisai Anti-obesity Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 79. Global Anti-obesity Drugs Sales by Manufacturer (2018-2019) (K Units)
Table 80. Global Anti-obesity Drugs Revenue by Manufacturer (2018-2019) (USD Million)
Table 81. Global Anti-obesity Drugs Sales by Regions (2015-2020) (K Units)
Table 82. Global Anti-obesity Drugs Sales Market Share by Regions (2015-2020)
Table 83. Global Anti-obesity Drugs Revenue by Regions (2015-2020) (USD Million)
Table 84. North America Anti-obesity Drugs Sales by Countries (2015-2020) (K Units)
Table 85. North America Anti-obesity Drugs Sales Market Share by Countries (2015-2020)
Table 86. North America Anti-obesity Drugs Revenue by Countries (2015-2020) (USD Million)
Table 87. North America Anti-obesity Drugs Revenue Market Share by Countries (2015-2020)
Table 88. Europe Anti-obesity Drugs Sales by Countries (2015-2020) (K Units)
Table 89. Europe Anti-obesity Drugs Sales Market Share by Countries (2015-2020)
Table 90. Europe Anti-obesity Drugs Revenue by Countries (2015-2020) (USD Million)
Table 91. Asia-Pacific Anti-obesity Drugs Sales by Regions (2015-2020) (K Units)
Table 92. Asia-Pacific Anti-obesity Drugs Sales Market Share by Regions (2015-2020)
Table 93. Asia-Pacific Anti-obesity Drugs Revenue by Regions (2015-2020) (USD Million)
Table 94. South America Anti-obesity Drugs Sales by Countries (2015-2020) (K Units)
Table 95. South America Anti-obesity Drugs Sales Market Share by Countries (2015-2020)
Table 96. South America Anti-obesity Drugs Revenue by Countries (2015-2020) (USD Million)
Table 97. South America Anti-obesity Drugs Revenue Market Share by Countries (2015-2020)
Table 98. Middle East & Africa Anti-obesity Drugs Sales by Countries (2015-2020) (K Units)
Table 99. Middle East & Africa Anti-obesity Drugs Sales Market Share by Countries (2015-2020)
Table 100. Middle East & Africa Anti-obesity Drugs Revenue by Countries (2015-2020) (USD Million)
Table 101. Middle East & Africa Anti-obesity Drugs Revenue Market Share by Countries (2015-2020)
Table 102. Global Anti-obesity Drugs Sales by Type (2015-2020) (K Units)
Table 103. Global Anti-obesity Drugs Sales Share by Type (2015-2020)
Table 104. Global Anti-obesity Drugs Revenue by Type (2015-2020) (USD Million)
Table 105. Global Anti-obesity Drugs Revenue Share by Type (2015-2020)
Table 106. Global Anti-obesity Drugs Sales by Application (2015-2020) (K Units)
Table 107. Global Anti-obesity Drugs Sales Share by Application (2015-2020)
Table 108. Global Anti-obesity Drugs Sales Forecast by Regions (2021-2025) (K Units)
Table 109. Global Anti-obesity Drugs Market Share Forecast by Regions (2021-2025)
Table 110. Global Anti-obesity Drugs Sales Forecast by Type (2021-2025) (K Units)
Table 111. Global Anti-obesity Drugs Market Share Forecast by Type (2021-2025)
Table 112. Global Anti-obesity Drugs Sales Forecast by Application (2021-2025)
Table 113. Global Anti-obesity Drugs Market Share Forecast by Application (2021-2025)
Table 114. Direct Channel Pros & Cons
Table 115. Indirect Channel Pros & Cons
Table 116. Distributors/Traders/ Dealers List
List of Figures
Figure 1. Anti-obesity Drugs Picture
Figure 2. Global Sales Market Share of Anti-obesity Drugs by Type in 2019
Figure 3. Peripherally Acting Anti-obesity Drugs Picture
Figure 4. Centrally Acting Anti-obesity Drugs Picture
Figure 5. Anti-obesity Drugs Sales Market Share by Application in 2018
Figure 6. Kids Picture
Figure 7. Adults Picture
Figure 8. Global Anti-obesity Drugs Market Status and Outlook (2015-2025) (USD Million)
Figure 9. United States Anti-obesity Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 10. Canada Anti-obesity Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 11. Mexico Anti-obesity Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 12. Germany Anti-obesity Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 13. France Anti-obesity Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 14. UK Anti-obesity Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 15. Russia Anti-obesity Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 16. Italy Anti-obesity Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 17. China Anti-obesity Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 18. Japan Anti-obesity Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 19. Korea Anti-obesity Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 20. India Anti-obesity Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 21. Southeast Asia Anti-obesity Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 22. Australia Anti-obesity Drugs Revenue (Value) and Growth Rate (2015-2025) (USD Million)
Figure 23. Brazil Anti-obesity Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 24. Egypt Anti-obesity Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 25. Saudi Arabia Anti-obesity Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 26. South Africa Anti-obesity Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 27. Turkey Anti-obesity Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 28. Global Anti-obesity Drugs Sales Market Share by Manufacturer in 2019
Figure 29. Global Anti-obesity Drugs Revenue Market Share by Manufacturer in 2019
Figure 30. Top 3 Anti-obesity Drugs Manufacturer (Revenue) Market Share in 2019
Figure 31. Top 6 Anti-obesity Drugs Manufacturer (Revenue) Market Share in 2019
Figure 32. Key Manufacturer Market Share Trend
Figure 33. Global Anti-obesity Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 34. Global Anti-obesity Drugs Revenue and Growth Rate (2015-2020) (USD Million)
Figure 35. Global Anti-obesity Drugs Revenue Market Share by Regions (2015-2020)
Figure 36. Global Anti-obesity Drugs Revenue Market Share by Regions in 2018
Figure 37. North America Anti-obesity Drugs Sales and Growth Rate (2015-2020)
Figure 38. Europe Anti-obesity Drugs Sales and Growth Rate (2015-2020)
Figure 39. Asia-Pacific Anti-obesity Drugs Sales and Growth Rate (2015-2020)
Figure 40. South America Anti-obesity Drugs Sales and Growth Rate (2015-2020)
Figure 41. Middle East & Africa Anti-obesity Drugs Sales and Growth Rate (2015-2020)
Figure 42. North America Anti-obesity Drugs Revenue and Growth Rate (2015-2020) (USD Million)
Figure 43. North America Anti-obesity Drugs Sales Market Share by Countries (2015-2020)
Figure 44. North America Anti-obesity Drugs Sales Market Share by Countries in 2018
Figure 45. North America Anti-obesity Drugs Revenue Market Share by Countries (2015-2020) (USD Million)
Figure 46. North America Anti-obesity Drugs Revenue Market Share by Countries in 2018
Figure 47. United States Anti-obesity Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 48. Canada Anti-obesity Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 49. Mexico Anti-obesity Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 50. Europe Anti-obesity Drugs Revenue and Growth Rate (2015-2020) (USD Million)
Figure 51. Europe Anti-obesity Drugs Revenue Market Share by Countries (2015-2020)
Figure 52. Europe Anti-obesity Drugs Revenue Market Share by Countries in 2019
Figure 53. Germany Anti-obesity Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 54. UK Anti-obesity Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 55. France Anti-obesity Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 56. Russia Anti-obesity Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 57. Italy Anti-obesity Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 58. Asia-Pacific Anti-obesity Drugs Revenue and Growth Rate (2015-2020) (USD Million)
Figure 59. Asia-Pacific Anti-obesity Drugs Sales Market Share by Regions 2019
Figure 60. Asia-Pacific Anti-obesity Drugs Revenue Market Share by Regions 2019
Figure 61. China Anti-obesity Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 62. Japan Anti-obesity Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 63. Korea Anti-obesity Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 64. India Anti-obesity Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 65. Southeast Asia Anti-obesity Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 66. South America Anti-obesity Drugs Revenue and Growth Rate (2015-2020) (USD Million)
Figure 67. South America Anti-obesity Drugs Sales Market Share by Countries in 2019
Figure 68. South America Anti-obesity Drugs Revenue Market Share by Countries in 2019
Figure 69. Brazil Anti-obesity Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 70. Argentina Anti-obesity Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 71. Middle East and Africa Anti-obesity Drugs Revenue and Growth Rate (2015-2020) (USD Million)
Figure 72. Middle East and Africa Anti-obesity Drugs Sales Market Share by Countries in 2019
Figure 73. Middle East and Africa Anti-obesity Drugs Revenue Market Share by Countries (2015-2020)
Figure 74. Middle East and Africa Anti-obesity Drugs Revenue Market Share by Countries in 2019
Figure 75. Saudi Arabia Anti-obesity Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 76. Egypt Anti-obesity Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 77. Turkey Anti-obesity Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 78. South Africa Anti-obesity Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 79. Global Anti-obesity Drugs Sales and Growth Rate (2021-2025) (K Units)
Figure 80. Global Anti-obesity Drugs Revenue and Growth Rate (2021-2025) (USD Million)
Figure 81. North America Sales Anti-obesity Drugs Market Forecast (2021-2025) (K Units)
Figure 82. Europe Sales Anti-obesity Drugs Market Forecast (2021-2025) (K Units)
Figure 83. Asia-Pacific Sales Anti-obesity Drugs Market Forecast (2021-2025) (K Units)
Figure 84. South America Sales Anti-obesity Drugs Market Forecast (2021-2025) (K Units)
Figure 85. Middle East & Africa Sales Anti-obesity Drugs Market Forecast (2021-2025) (K Units)
Figure 86. Sales Channel: Direct Channel vs Indirect Channel
アンチエイジング薬の世界市場2020年：メーカー別、地域別、種類・用途別 Market Overview The global Anti-aging Drugs market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Anti-aging Drugs market repo…- 非ステロイド性抗炎症薬（NSAID）の世界市場2020年：企業別、地域別、種類・用途別 Market Overview The global Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The…
- 肥満治療神経調節システムの世界市場2020年：メーカー別、地域別、種類・用途別 Market Overview The global Obesity Treating Neuromodulation System market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Obesi…
- 肥満手術装置の世界市場2020年：メーカー別、地域別、種類・用途別 Market Overview The global Obesity Surgery Device market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Obesity Surgery Device…
- 肥満治療装置の世界市場2020年：メーカー別、地域別、種類・用途別 Market Overview The Obesity Treatment Devices market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimizat…